PDT Partners’s Loxo Oncology, Inc LOXO Stock Holding History

PDT Partners’s Portfolio LOXO Stock Details LOXO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q1	–	Sell	-14,831	Closed	-$422K	–	618
2015 Q4	$422K	Buy	+14,831	New	+$398K	0.06%	289

Other funds holding LOXO

Aisling Capital New York $45.3M AUM 15.24% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

NMC

NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return

RIM

RS Investment Management San Francisco, California $9.73B AUM 3.24% 1-Year Est. Return

EAM

Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

DCM

Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return

PointState Capital New York $7.9B AUM 42.31% 1-Year Est. Return

PDT Partners's LOXO Position: Q1 2016 in Review

PDT Partners sold out of Loxo Oncology, Inc (LOXO) in Q1 2016, closing a stake of 14,831 shares — an estimated $422K sold.

PDT Partners first reported a position in LOXO in Q4 2015 and held it in 1 quarter. The position peaked at $422K in Q4 2015. 67 funds tracked by Wall St. Rank hold LOXO as of Q1 2016.

PDT Partners reported no remaining Loxo Oncology, Inc position as of Q1 2016 after selling out during the quarter.
PDT Partners sold 14,831 Loxo Oncology, Inc shares in Q1 2016, an estimated $422K.
PDT Partners first reported a position in Loxo Oncology, Inc in Q4 2015 and held it in 1 quarter.
PDT Partners's Loxo Oncology, Inc position peaked at $422K in Q4 2015.
67 funds tracked by Wall St. Rank held Loxo Oncology, Inc as of Q1 2016.

Based on PDT Partners's 13F filing for Q1 2016, filed 16 May 2016.